Voichita B. Ad
Experienced in Eccrine Porocarcinoma

Dr. Voichita B. Ad

Radiation Oncology
111 South 11th Street, Suite G-301, 
Philadelphia, PA 
Accepting New Patients
Offers Telehealth
Experienced in Eccrine Porocarcinoma
111 South 11th Street, Suite G-301, 
Philadelphia, PA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Voichita Ad is a Radiation Oncologist in Philadelphia, Pennsylvania. Dr. Ad is rated as an Experienced provider by MediFind in the treatment of Eccrine Porocarcinoma. Her top areas of expertise are Gliosarcoma, Embryonal Tumor with Multilayered Rosettes, Neuroepithelioma, Atypical Teratoid Rhabdoid Tumor (ATRT), and Gamma Knife Radiosurgery. Dr. Ad is currently accepting new patients.

Her clinical research consists of co-authoring 11 peer reviewed articles and participating in 8 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Institution
University Of Medicine & Pharmacy, Romania
Residency
The Hebrew University Hadassah Medical School
Specialties
Radiation Oncology
Licenses
Radiology in PA
Board Certifications
Radiology
Radiation Oncology
Fellowships
Hospital of the University of Pennsylvania
Hospital Affiliations
Jefferson Methodist Hospital
Thomas Jefferson University Hospital
Languages Spoken
English
Hebrew
Romanian
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Geisinger
  • HMO
  • POS
  • PPO
Health Partners Plans
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
PA Health and Wellness
  • HMO
  • MANAGED MEDICAID PLAN
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
UPMC
  • EPO
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 8 Less Insurance Carriers -

Locations

Radiation Oncology at Thomas Jefferson University Hospital
111 South 11th Street, Suite G-301, Philadelphia, PA 19107

Additional Areas of Focus

Dr. Ad has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Astrocytoma
Adrenal Cancer

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

A Randomized Phase II/III Trial of De-Intensified Radiation Therapy for Patients With Early-Stage, P16-Positive, Non-Smoking Associated Oropharyngeal Cancer
A Randomized Phase II/III Trial of De-Intensified Radiation Therapy for Patients With Early-Stage, P16-Positive, Non-Smoking Associated Oropharyngeal Cancer
Enrollment Status: Active_not_recruiting
Publish Date: October 31, 2025
Intervention Type: Other, Procedure, Drug, Biological, Radiation
Study Drugs: Cisplatin, Nivolumab
Study Phase: Phase 2/Phase 3
A Pilot Study Using Surgical Resection and Intraoperative Cesium-131 Permanent Interstitial Brachytherapy Implant in Resectable Recurrent Head and Neck Cancer
A Pilot Study Using Surgical Resection and Intraoperative Cesium-131 Permanent Interstitial Brachytherapy Implant in Resectable Recurrent Head and Neck Cancer
Enrollment Status: Completed
Publish Date: September 19, 2025
Intervention Type: Drug, Radiation, Procedure
Study Phase: Early Phase 1
Phase I Trial of High Dose Rate Brachytherapy Combined With Stereotactic Body Radiation Therapy for Intermediate Risk Prostate Cancer Patients
Phase I Trial of High Dose Rate Brachytherapy Combined With Stereotactic Body Radiation Therapy for Intermediate Risk Prostate Cancer Patients
Enrollment Status: Active_not_recruiting
Publish Date: September 11, 2025
Intervention Type: Radiation, Other, Procedure
Study Phase: Phase 1
A Pilot Trial of a Low-Carbohydrate Normocaloric Diet, in Patients With Head and Neck Carcinoma (HNC) and Its Effect on Stromal-Epithelial Metabolic Uncoupling
A Pilot Trial of a Low-Carbohydrate Normocaloric Diet, in Patients With Head and Neck Carcinoma (HNC) and Its Effect on Stromal-Epithelial Metabolic Uncoupling
Enrollment Status: Completed
Publish Date: May 20, 2025
Intervention Type: Dietary supplement
Study Phase: Not Applicable
TELEPORT STUDY: A Pilot Feasibility Trial Examining The Use of Telehealth in Post Radiation Therapy Visits
TELEPORT STUDY: A Pilot Feasibility Trial Examining The Use of Telehealth in Post Radiation Therapy Visits
Enrollment Status: Completed
Publish Date: May 16, 2025
Intervention Type: Other
Study Phase: Not Applicable
An Exploratory Study to Investigate the Immunomodulatory Activity of Radiation Therapy (RT) in Combination With MK-3475 in Patients With Recurrent/Metastatic Head and Neck, Renal Cell Cancer, Melanoma and Lung Cancer
An Exploratory Study to Investigate the Immunomodulatory Activity of Radiation Therapy (RT) in Combination With MK-3475 in Patients With Recurrent/Metastatic Head and Neck, Renal Cell Cancer, Melanoma and Lung Cancer
Enrollment Status: Completed
Publish Date: May 15, 2025
Intervention Type: Radiation, Drug
Study Drug: MK-3475
Study Phase: Phase 1
Phase I Study of Alisertib With Concurrent Fractionated Stereotactic Radiation Treatment for Recurrent High Grade Gliomas
Phase I Study of Alisertib With Concurrent Fractionated Stereotactic Radiation Treatment for Recurrent High Grade Gliomas
Enrollment Status: Completed
Publish Date: April 30, 2025
Intervention Type: Drug, Radiation, Procedure
Study Phase: Phase 1
A Randomized Phase II/Phase III Study of Adjuvant Concurrent Radiation and Chemotherapy Versus Radiation Alone in Resected High-Risk Malignant Salivary Gland Tumors
A Randomized Phase II/Phase III Study of Adjuvant Concurrent Radiation and Chemotherapy Versus Radiation Alone in Resected High-Risk Malignant Salivary Gland Tumors
Enrollment Status: Active_not_recruiting
Publish Date: February 13, 2025
Intervention Type: Drug, Radiation
Study Drug: Cisplatin
Study Phase: Phase 2
View 7 Less Clinical Trials

11 Total Publications

Nivolumab and ipilimumab in combination with radiotherapy in patients with high-risk locally advanced squamous cell carcinoma of the head and neck.
Nivolumab and ipilimumab in combination with radiotherapy in patients with high-risk locally advanced squamous cell carcinoma of the head and neck.
Journal: Journal for immunotherapy of cancer
Published: July 16, 2023
Similar Doctors
Advanced in Eccrine Porocarcinoma
Dr. Et-tsu Chen
Radiation Oncology
Advanced in Eccrine Porocarcinoma
Dr. Et-tsu Chen
Radiation Oncology

Penn Radiation Oncology Valley Forge

1001 Chesterbrook Boulevard, 
Berwyn, PA 
 (18.0 miles away)
800-789-7366
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Et-tsu Chen is a Radiation Oncologist in Berwyn, Pennsylvania. Dr. Chen is rated as a Distinguished provider by MediFind in the treatment of Eccrine Porocarcinoma. Her top areas of expertise are Anal Cancer, Intraductal Papilloma, Primary Lymphoma of the Brain, and Familial Prostate Cancer. Dr. Chen is currently accepting new patients.

Advanced in Eccrine Porocarcinoma
Dr. James C. Wurzer
Radiation Oncology
Advanced in Eccrine Porocarcinoma
Dr. James C. Wurzer
Radiation Oncology

New Jersey Health Network LLC

2500 English Creek Ave, Suite 400, 
Egg Harbor Township, NJ 
 (46.1 miles away)
609-677-7700
Languages Spoken:
English
See accepted insurances

James Wurzer is a Radiation Oncologist in Egg Harbor Township, New Jersey. Dr. Wurzer is rated as a Distinguished provider by MediFind in the treatment of Eccrine Porocarcinoma. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Adenoid Cystic Carcinoma, and Breast Cancer.

Experienced in Eccrine Porocarcinoma
Dr. Thomas J. Galloway
Radiation Oncology
Experienced in Eccrine Porocarcinoma
Dr. Thomas J. Galloway
Radiation Oncology

Temple Faculty Practice Plan Inc

3401 N Broad St, 
Philadelphia, PA 
 (3.9 miles away)
215-707-5030
Languages Spoken:
English
See accepted insurances

Thomas Galloway is a Radiation Oncologist in Philadelphia, Pennsylvania. Dr. Galloway is rated as a Distinguished provider by MediFind in the treatment of Eccrine Porocarcinoma. His top areas of expertise are Laryngeal Cancer, Throat Cancer, Adenoid Cystic Carcinoma, Tongue Cancer, and Glossectomy.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Ad's expertise for a condition
ConditionClose
    View All 9 Distinguished Conditions
    View All 23 Advanced Conditions
    View All 34 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile